Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure
Frontiers in Cardiovascular Medicine · 01.06.2026 · 13
DOI: 10.3389/fcvm.2026.1751022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 01.06.2026. Verfasst von Huijuan Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Hospital of Changsha, Changsha, China. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Heart failure (HF) is a major health threat, with aging and programmed cell death (PCD) playing key roles. However, the link between aging-related PCD (aging-PCD) genes and HF remains unclear.
Methods
We used ssGSEA and random forest to analyze PCD types in HF, identified aging-related PCDs via correlation analysis, and applied eight machine learning algorithms to develop a diagnostic model. SHAP and LIME were used to explain key features, and the relationship between the aging-PCD index and immune microenvironment was explored. Gene expression was verified by qRT-PCR, and the function of STEAP3 was further investigated in an H 2 O 2 -induced AC16 cell model. Ferroptosis-related changes were assessed by measuring reactive oxygen species (ROS), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and ferrous ion (Fe 2+ ) levels.
Results
Ferroptosis, autophagy, and necroptosis were strongly correlated with aging in HF. Eighteen differentially expressed aging-related PCD genes were identified. The LASSO model showed the best diagnostic performance. Significant differences in the immune microenvironment were observed between the aging-PCD index-high and index-low groups. A regulatory network of 15 key genes and 19 transcription factors was constructed. The qRT-PCR results validated the bioinformatics analysis. Functional experiments further suggested that STEAP3 may participate in ferroptosis-related injury in cardiomyocytes, potentially through glutathione metabolism (GPX4/SLC7A11 axis) and iron homeostasis.
Conclusion
We identified aging-related PCD signatures in HF that may provide candidate biomarkers for further clinical validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The First Hospital of Changsha, Changsha, China.
- School of Medicine, Yueyang Vocational Technical College, Yueyang, China.
Zitieren
APA
Chen, H., & Xu, L. (2026). Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1751022
Vancouver
Chen H, Xu L. Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1751022
BibTeX
@article{Chen2026,
author = {Chen, Huijuan and Xu, Lingqi},
title = {Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1751022}
}
EUVIMED